Е. В. Зонова

490 total citations
21 papers, 162 citations indexed

About

Е. В. Зонова is a scholar working on Rheumatology, Pharmacology and Oncology. According to data from OpenAlex, Е. В. Зонова has authored 21 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 5 papers in Pharmacology and 5 papers in Oncology. Recurrent topics in Е. В. Зонова's work include Rheumatoid Arthritis Research and Therapies (8 papers), Osteoarthritis Treatment and Mechanisms (5 papers) and Inflammatory mediators and NSAID effects (4 papers). Е. В. Зонова is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Osteoarthritis Treatment and Mechanisms (5 papers) and Inflammatory mediators and NSAID effects (4 papers). Е. В. Зонова collaborates with scholars based in Russia, Belarus and United States. Е. В. Зонова's co-authors include D. G. Krechikova, Samsonov MIu, Eugen Feist, Mariana Ivanova, Румен Стоилов, Saeed Fatenejad, Mark C. Genovese, Mazurov Vi, P. А. Shesternya and Alexander Kulagin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lupus.

In The Last Decade

Е. В. Зонова

16 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Е. В. Зонова Russia 6 111 62 50 30 18 21 162
Peigen He China 6 86 0.8× 48 0.8× 30 0.6× 17 0.6× 14 0.8× 8 147
Xavier M Teitsma Netherlands 7 132 1.2× 35 0.6× 53 1.1× 23 0.8× 16 0.9× 16 181
Asta Linauskas Denmark 6 105 0.9× 22 0.4× 39 0.8× 26 0.9× 9 0.5× 15 146
Susumu Kitamura Japan 6 63 0.6× 146 2.4× 40 0.8× 26 0.9× 19 1.1× 6 220
Marian H. van Beers-Tas Netherlands 9 197 1.8× 43 0.7× 52 1.0× 33 1.1× 21 1.2× 13 247
Cecilie Heegaard Brahe Denmark 6 138 1.2× 20 0.3× 56 1.1× 34 1.1× 6 0.3× 13 162
Pierre‐Edouard Gavand France 5 115 1.0× 66 1.1× 12 0.2× 21 0.7× 9 0.5× 8 144
Ben Hargreaves United Kingdom 5 66 0.6× 29 0.5× 20 0.4× 16 0.5× 32 1.8× 12 145
Sabrina Porta Argentina 4 134 1.2× 73 1.2× 11 0.2× 20 0.7× 9 0.5× 6 159
L. Myasoutova Russia 5 226 2.0× 175 2.8× 60 1.2× 12 0.4× 8 0.4× 14 261

Countries citing papers authored by Е. В. Зонова

Since Specialization
Citations

This map shows the geographic impact of Е. В. Зонова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Е. В. Зонова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Е. В. Зонова more than expected).

Fields of papers citing papers by Е. В. Зонова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Е. В. Зонова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Е. В. Зонова. The network helps show where Е. В. Зонова may publish in the future.

Co-authorship network of co-authors of Е. В. Зонова

This figure shows the co-authorship network connecting the top 25 collaborators of Е. В. Зонова. A scholar is included among the top collaborators of Е. В. Зонова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Е. В. Зонова. Е. В. Зонова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Зонова, Е. В., Л. И. Алексеева, & А. М. Лила. (2025). Chronic pain and group B vitamins. Modern Rheumatology Journal. 19(1). 91–97.
2.
Таскина, Е. А., et al.. (2024). The influence of type 2 diabetes mellitus on clinical manifestations of osteoarthritis. SHILAP Revista de lepidopterología. 18(4). 51–58.
3.
4.
Алексеева, Л. И., et al.. (2023). Results of a clinical study of Traumeel® S and Zeel® T in patients with knee osteoarthritis and concomitant cardiovascular disease. SHILAP Revista de lepidopterología. 17(5). 79–86.
5.
Насонов, Е. Л., et al.. (2023). The use of methotrexate in rheumatoid arthritis. Recommendations of the All-Russian public organization “Association of Rheumatologists of Russia”. SHILAP Revista de lepidopterología. 61(4). 435–449. 2 indexed citations
6.
Лила, А. М., Mazurov Vi, Martynov Ai, et al.. (2022). Resolution of the consensus of the Russian Federation experts on the diagnosis and treatment of osteoarthritis, 2022. SHILAP Revista de lepidopterología. 16(6). 106–116. 5 indexed citations
7.
Зонова, Е. В., et al.. (2022). The use of febuxostat in comorbid patients with gout in real clinical practice: own data. SHILAP Revista de lepidopterología. 16(3). 75–80.
8.
9.
Эрдес, Ш. Ф., Е. Л. Насонов, P. А. Shesternya, et al.. (2020). Primary efficacy of netakimab, a novel interleukin-17 inhibitor, in the treatment of active ankylosing spondylitis in adults.. PubMed. 38(1). 27–34. 34 indexed citations
10.
Авдеев, С. Н., et al.. (2020). The resolution of the Expert Council on Interstitial Lung Diseases in Systemic Scleroderma (Moscow, October 14, 2019). SHILAP Revista de lepidopterología. 14(1). 125–128. 5 indexed citations
11.
Таскина, Е. А., et al.. (2018). FRI0545 Risk factors predicting radiological progression of knee osteoarthritis. Annals of the Rheumatic Diseases. 77. 797–798. 1 indexed citations
12.
Гордеев, И. Г., Mazurov Vi, А. М. Лила, et al.. (2017). FRI0208 Comparison of efficacy, safety and pharmacokinetics of infliximab biosimilar (BCD-055) and innovator infliximab. Annals of the Rheumatic Diseases. 76. 560–561. 1 indexed citations
13.
Sazonova, Olga V., et al.. (2017). AB0795 Osteoarthritis and comorbidity: association between mental features and cytokines levels. Annals of the Rheumatic Diseases. 76. 1336–1336. 1 indexed citations
14.
Зонова, Е. В., et al.. (2016). Characterization of osteoarthritis in patients with diabetes mellitus type 2. Integrative Molecular Medicine. 3(3). 649–653. 2 indexed citations
15.
Nasonov, E L, Е. В. Зонова, О.Н. Иванова, et al.. (2016). THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY). Rheumatology Science and Practice. 54(5). 510–519. 21 indexed citations
16.
Sazonova, Olga V., et al.. (2016). AB0752 The Association between Clinical Symptoms and Serum Cytokines Levels in Patients with Knee Osteoarthritis and Comorbidity. Annals of the Rheumatic Diseases. 75. 1162–1162. 2 indexed citations
17.
18.
19.
Коненков, В. И., et al.. (2010). [Pharmacogenetic criteria for the efficacy of basic anti-inflammatory therapy for rheumatoid arthritis].. PubMed. 82(12). 56–61. 2 indexed citations
20.
Lisukov, Igor, Alexander Kulagin, Е. В. Зонова, et al.. (2004). High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus. Lupus. 13(2). 89–94. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peigen He Breakdown of academic impact, for papers by Xavier M Teitsma Breakdown of academic impact, for papers by Asta Linauskas Breakdown of academic impact, for papers by Susumu Kitamura Breakdown of academic impact, for papers by Marian H. van Beers-Tas Breakdown of academic impact, for papers by Cecilie Heegaard Brahe Breakdown of academic impact, for papers by Pierre‐Edouard Gavand Breakdown of academic impact, for papers by Ben Hargreaves Breakdown of academic impact, for papers by Sabrina Porta Breakdown of academic impact, for papers by L. Myasoutova
Rankless by CCL
2026